Apple: Is WWDC 2025 A Warning Signal For Future Growth?
June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success
May 27, 2025 How much does a Turkish passport cost?
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
Canopy Growth (CGC) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: June 18, 2025 (10:41)
Sector: HealthcareThe share price of Canopy Growth Corp. (CGC) now
News Impact Analyzer
Full report
This Week
|
Na | Impact: Na | News: Na |
Previous Week
|
Na | Impact: Na | News: Na |
Two Weeks Ago
|
Bearish | Impact: 5 | News: 6 |
Three Weeks Ago
|
Na | Impact: Na | News: Na |
Analysts predictions
Full report
This Week
|
Neutral | Opinions: Na |
Previous Week
|
Neutral | Opinions: Na |
Two Weeks Ago
|
Neutral | Opinions: Na |
Three Weeks Ago
|
Neutral | Opinions: Na |
Analyzing the Most Important CGC news

Canopy Growth Tightens Belt with $20M Savings Plan Amid Revenue Challenges


Canopy Growth Plunges 12% on Revenue and Earnings Miss in Q4


Canopy Growth Shows Mixed Signals: Growth in Cannabis but Decline in Storz & Bickel

Historical and forecast chart of Canopy Growth stock
The chart below shows the historical price of Canopy Growth stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Canopy Growth stock price can be found in the table below.
Long-term forecasts by years.
Canopy Growth Corp. Analysts predictions review

Canopy Growth Corporation faces significant financial and operational challenges that weigh heavily on its stock outlook. Persistent issues include high debt levels, continued cash burn, and a deteriorating revenue base. The company’s struggles with inefficient cost management, declining market share, and regulatory uncertainties in key markets further exacerbate these concerns. Elevated competitive pressures and limited pricing power weaken growth prospects, while the absence of catalysts for a turnaround raises doubts about near-term recovery potential. Weak fundamentals and strained liquidity amplify downside risks, keeping investor sentiment strongly negative.

Evaluate with Caution: Canopy Growth Faces Persistent Challenges

Canopy Growth Corporation's recent stock bounce appears unsustainable due to underlying financial challenges. The company's precarious balance sheet, characterized by high debt levels and ongoing cash burn, remains a significant risk factor. If these trends persist, they may continue to pressure both investor confidence and stock valuation in the near term.
Strategic Positioning and Market Realities
The competitive pressures within the cannabis industry, coupled with regulatory uncertainties, complicate Canopy's ability to achieve profitability. Weak pricing power and struggles in capturing market share further impair revenue growth potential, weighing on the stock's forward-looking trajectory.
Finally, the author's assessment emphasizes the limited catalysts for a near-term turnaround. Without meaningful improvements in cost structure or operational efficiency, the bounce seen in CGC's stock is unlikely to establish lasting upward momentum.

Canopy Growth Struggles With Steep Losses and Declining Revenues: A Warning Sign for Investors

Canopy Growth Company's latest financial results reveal a sharp net loss coupled with a deterioration in revenue, underscoring persistent operational and market challenges. The reported figures highlight an unfavorable trend in the company’s ability to sustain growth or manage profitability during a time of heightened competition and sector stagnation.
The author emphasizes that high net losses are a reflection of Canopy Growth’s ongoing cash burn and inefficiency in cost management. This puts significant pressure on its liquidity and raises concerns about the long-term viability of its current operating model, dampening investor confidence.
Competition and Sector Dynamics Amplify Risks
Lower revenues suggest deteriorating market positioning, possibly due to weaker demand for Canopy's products or intensified competition across the cannabis sector. This issue, compounded by global economic headwinds, may result in further declines in market share, leaving the company vulnerable to broader industry cyclicality.
Lastly, the sentiment surrounding Canopy Growth has shifted sharply negative due to these financial setbacks, as evidenced by declining investor interest and a falling stock price. If management fails to demonstrate a credible turnaround plan, the bearish sentiment could persist and weigh heavily on the stock's near-term performance.

Strategic Retreat: Evaluating Canopy Growth's Diminishing Prospects

Canopy Growth's recent financial performance and operational challenges have raised serious concerns about its ability to sustain growth in the competitive cannabis market. Their continued struggle with declining revenues, mounting losses, and an ineffective cost-cutting strategy significantly impacts investor confidence and dampens prospects for a near-term recovery.
The evolving regulatory environment in key markets, including the United States and Canada, has further constrained Canopy Growth’s ability to capitalize on emerging opportunities. The author highlights that regulatory delays in cannabis legalization threaten the company's ability to gain traction in higher-margin markets, exacerbating growth constraints.
Debt Management and Market Positioning
The company’s high debt burden and ongoing restructuring efforts raise questions about its long-term solvency and ability to navigate periods of economic uncertainty. According to the author, insufficient cash reserves to cover immediate obligations create heightened financial risk, underscoring the urgency for strategic redirection.
Finally, Canopy Growth's market positioning has deteriorated due to intense competition and a lack of differentiation in product offerings. The absence of clear competitive advantages, as noted by the author, has hindered its ability to capture market share, leaving investors with limited optimism about future returns. Combined with weak fundamentals, these factors suggest that the company is entering a critical period of uncertainty.
Canopy Growth's financial instability stands out as a critical concern, with recurring operating losses and aggressive cash burn raising questions about long-term viability. The likelihood of insolvency grows as liquidity pressures intensify, leaving the company vulnerable to external shocks or funding delays. As highlighted by the author, these dynamics weigh heavily on the stock’s potential recovery.
Delisting Threats and Management's Strategic Struggles
The looming delisting threat exacerbates investor concerns, putting direct pressure on the stock price as the company risks losing access to broader liquidity and institutional interest. Poor execution by management in turning around the business has further compounded confidence issues, as evidenced by lackluster outcomes from restructuring efforts.
Market competition and regulatory hurdles remain persistent headwinds, with various peers more adeptly managing profitability and compliance. The inability to differentiate its products or achieve sustainable growth metrics leaves Canopy Growth in a precarious position, intensifying investor caution.
Canopy Growth's declining revenue trajectory is a central concern, with the company facing mounting competition and oversaturation in the cannabis market. Analyst Array emphasizes that the lack of meaningful sales growth could continue to weigh heavily on investor sentiment and stock performance.
The author highlights Canopy Growth's ongoing cash burn and deteriorating balance sheet as key risks. With limited operational efficiency, these issues raise doubts about the firm's ability to sustain its long-term growth strategy without further dilution or external financing.
Strategic Pressure on CGC
The company's entrance into the U.S. cannabis market presents both an opportunity and a challenge. While expansion into the lucrative American market could drive future growth, Array notes that regulatory hurdles and heightened competition significantly diminish upside potential.
Weak macroeconomic conditions and reduced consumer discretionary spending are additional headwinds cited by Array. These factors are likely to exacerbate Canopy Growth's profitability challenges and limit near-term stock momentum.
Canopy Growth’s Q3 earnings results indicated some improvement in financial performance, with cost-cutting efforts and operational streamlining contributing to a narrowing of losses. However, while this is a step in the right direction, the broader market challenges, including oversupply and underwhelming demand, remain significant obstacles to sustained profitability.
Key Issues Facing Canopy Growth
The competitive pressures within the cannabis industry continue to weigh heavily on CGC, as pricing power is constrained by intense market fragmentation. The author underscores this dynamic, which diminishes the company’s ability to expand margins despite operational improvements.
Regulatory hurdles in key markets, particularly in the U.S. and Canada, further complicate Canopy Growth’s path to sustainable growth. According to the article, legislative bottlenecks and the slow pace of market liberalization hinder the company’s expansion plans.
Persistent weakness in consumer sentiment across the cannabis sector also limits revenue growth potential. The author asserts that this sluggish demand, driven in part by economic uncertainty, exacerbates pricing pressure and delays the industry's recovery.
While cost discipline and operational initiatives provide short-term relief, their long-term impact is contingent on macro and sector-specific factors. Thus, these efforts, though pivotal, are unlikely to overcome the systemic obstacles facing CGC and the cannabis industry as a whole.
Weak revenue momentum and declining market share continue to underscore Canopy Growth's struggle to establish a sustainable competitive advantage in the cannabis industry. The author notes that despite the company's attempts to pivot its strategy, inconsistent operational performance has hindered its ability to capitalize on market opportunities.
High cash burn and liquidity challenges raise significant concerns about the company's ability to fund its operations in the medium term. As the author highlights, with no clear path to profitability, Canopy's financial health remains vulnerable to further macroeconomic headwinds and operational missteps.
Structural Challenges and Industry Dynamics
Regulatory uncertainty and growing competition in the cannabis sector present additional hurdles for Canopy Growth. While the company attempts to diversify its product lines and expand internationally, the author questions whether these efforts can offset domestic pressures and achieve meaningful revenue growth.
A volatile geopolitical and economic environment exacerbates risks for investors. Combined with the internal challenges discussed, these external pressures heighten uncertainty for Canopy's outlook in both the near and medium-term.
Canopy Growth Corporation’s struggles with balance sheet weakness remain a significant headwind, as high debt levels and recurring cash burn hinder its ability to navigate market challenges or fund new growth initiatives. The financial vulnerability positions CGC at a continued disadvantage amid a competitive cannabis industry landscape.
The sustained decline in revenue, exacerbated by regulatory complexities and softer demand in key markets, signals a lack of fundamental operational improvement. These conditions suggest limited near-term catalysts for a turnaround in the stock’s performance.
Macro and Strategic Pressures Intensify
Macro pressures, including rising interest rates and constrained access to capital, further stress CGC’s ability to fund operations or execute strategic pivots effectively. This economic backdrop compounds the company’s existing challenges, diminishing its attractiveness to risk-averse investors.
The absence of clear strategic differentiation, coupled with lackluster profitability metrics, casts doubt on CGC’s ability to establish a competitive moat. The market is unlikely to reward the stock with a premium valuation under these conditions without substantial evidence of sustained improvement.
Canopy Growth Corporation (CGC) is navigating a complex landscape shaped by regulatory uncertainty and competitive pressures within the cannabis industry. Analysts suggest that while CGC displays potential due to its established brand and diversified product portfolio, its growth is constrained by persistent delays in U.S. federal cannabis legalization, limiting its market expansion opportunities. This regulatory overhang continues to dampen investor sentiment and impacts near-term stock performance.
Revenue Growth and Operational Challenges
Profitability remains a key challenge for CGC as it experiences slower-than-expected revenue growth and compressed margins. Elevated costs and inefficiencies in its operational framework further strain its financials, raising concerns about the company's ability to achieve sustainable profitability. In addition, mounting competition within the cannabis sector threatens CGC’s market share, particularly from smaller companies with leaner cost structures and innovative strategies. This intensifies the pressure on the company to streamline operations and differentiate its offerings.
The company’s recent cost-cutting initiatives have been positively received by the market, providing a path toward improved operating leverage. However, these measures are seen as reactive rather than proactive, and their ultimate impact on long-term growth remains uncertain. Broader macroeconomic factors, such as rising interest rates and tightening financial conditions, also play a role in exacerbating bearish sentiment around high-growth stocks like CGC. Against this backdrop, investor attention is focused on management's ability to execute on key strategic initiatives that address these structural headwinds.
Canopy Growth Corporation (CGC) faces mounting challenges stemming from significant financial losses and an inability to achieve consistent profitability. The magnitude of these losses, combined with a capital-intensive industry, places downward pressure on investor sentiment and raises serious concerns about long-term viability.
Management's strategic initiatives to restructure operations and cut costs lack sufficient evidence of near-term turnaround potential. As highlighted by the author, these efforts may be undermined by an oversupplied cannabis market and declining pricing power, further dragging on revenue growth.
Macroeconomic Headwinds and Market Valuation
Macroeconomic uncertainty and rising interest rates exacerbate the company's struggles, given its debt-heavy balance sheet. This dynamic makes it increasingly difficult for CGC to secure favorable financing while highlighting liquidity risks in a competitive sector.
Finally, the stock's valuation appears disconnected from its fundamentals, trading at levels that overestimate its growth prospects. The author emphasizes that speculative demand may have inflated the stock price, leaving it vulnerable to correction as reality aligns with market expectations.
Sluggish financial performance continues to weigh on Canopy Growth Company's valuation, as weak fundamentals, including declining revenue and persistent operating losses, create a challenging environment for the firm to generate shareholder value. The company's inability to execute cost-efficiency measures effectively further dampens investor confidence, limiting its ability to navigate a highly competitive and capital-intensive cannabis market.
Headwinds in Growth Opportunities and Competitive Dynamics
Canopy Growth's struggles in establishing a sustainable growth trajectory are compounded by its difficulty in expanding market share within the cannabis industry, both domestically and internationally. The article highlights that this challenge is partially driven by regulatory burdens and oversupply issues, which have created pricing pressures and squeezed margins across the sector.
The firm's growth acceleration plans face considerable skepticism, as rising debt levels and constrained cash flow restrict its ability to invest in innovation and expansion. These financial pressures reduce CGC's strategic flexibility, potentially curbing its ability to capture new opportunities in emerging cannabis markets.
Macroeconomic uncertainties, including inflationary pressures and increasing interest rates, exacerbate the company's operational challenges, further limiting near-term recovery prospects. As Canopy Growth remains heavily reliant on external capital to sustain operations, these external factors pose risks that could accelerate downside pressure on the stock.
Canopy Growth Corporation (CGC) faces heightened pressure from consistent equity dilution, which continues to erode shareholder value. The company's repeated capital raises have diluted existing stakes, creating a significant headwind for the stock in the near term, especially in the context of a challenging cannabis sector backdrop.
Additionally, executive turnover further exacerbates uncertainties about CGC's strategic direction and operational efficiency. Leadership instability raises concerns over the effective execution of long-term strategies, potentially deterring investor confidence and institutional support.
Key Operational and Regulatory Risks
The delay in cannabis rescheduling at the federal level in the United States represents another critical impediment to Canopy's recovery trajectory. A lack of regulatory progress constrains growth opportunities in the U.S. market, which remains pivotal for the company's future expansion and profitability potential.
Lastly, broader industry dynamics, including oversupply and declining pricing power, compound the operational difficulties faced by CGC. These market forces further compress margins, creating additional pressure on management to stabilize financial performance amid rising competition.
Comprehensive Analysis of Canopy Growth (CGC) Stock Market Performance
Our multifaceted analysis of Canopy Growth's stock market is grounded in the company's key news stories, insights from reputable analysts, as well as mathematical and technical evaluations. Taking into account assessments from each of these aspects in real-time helps us address the most crucial questions for investors in the most objective way possible:
- When should I take profit in Canopy Growth stock?
- When should I record a loss on Canopy Growth stock?
- What are analysts' forecasts for Canopy Growth stock?
- What is the future of Canopy Growth stock?
We forecast Canopy Growth stock performance using neural networks based on historical data on Canopy Growth stocks.
Canopy Growth Corporation (CGC) is a prominent player in the cannabis industry, headquartered in Smiths Falls, Canada. The company specializes in cultivating and selling both medical and recreational cannabis, boasting a diverse portfolio of brands such as Tweed and 7ACRES.
Recently, Canopy reported a revenue of $46.18 million but faced a net loss of $96.45 million, reflecting ongoing financial challenges within the sector. Despite these struggles, Canopy has shown improvements in gross profit and adjusted EBITDA, indicating potential for recovery and growth.
Given its strategic positioning in the U.S. market and commitment to profitability, Canopy Growth could represent an intriguing investment opportunity for those willing to navigate its current volatility.
Canopy Growth Corp. News influencing stock rates

As of now, Panda has combed through 6 news items directly related to CGC from the last 30 days. Out of these, 0 clearly showcase a bullish trend, while 5 display bearish tendencies, and 1 events are neutral.
Based on an analysis of the most crucial news from the last 30 days affecting CGC stocks, it's clear that bearish sentiments are completely overshadowing bullish ones. The impact of negative news is more than five times dominant over positive developments.
The news analyzed fell within the period from May 29, 2025, to May 30, 2025.
Canopy Growth Posts Disappointing Q4 Results: Misses EPS & Revenue Estimates


Canopy Growth (CGC) Faces Alarming Risks for Poor Stock Performance


Canopy Growth Q4 Earnings: Mounting Losses and Revenue Challenges Ahead


Walmart CEO's Massive Share Sale: Insider Trading Alert


Canopy Growth Cuts $13M in Interest with Early Loan Prepayment


Canopy Growth Launches $200M Stock Sale Program


Canopy Growth Eyes Profitability with Efficiency and Innovation


Canopy Growth Posts Modest Gains: Canada Revenue +4.5%, Storz & Bickel Shines with +19.3%


Canopy Growth Shares Crumble 15% Following Wider Q3 Loss


Canopy Growth Posts Wider-Than-Expected Loss with Revenue Dip of 5% in Q3 FY2025


Canopy Growth daily forecast for a month
Date | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jun 20 | 1.34 | 1.33 | 1.37 | 3.06 |
Jun 21 | 1.36 | 1.35 | 1.38 | 2.36 |
Jun 22 | 1.35 | 1.34 | 1.37 | 2.51 |
Jun 23 | 1.35 | 1.33 | 1.37 | 3.13 |
Jun 24 | 1.34 | 1.31 | 1.36 | 3.74 |
Jun 25 | 1.36 | 1.34 | 1.39 | 3.40 |
Jun 26 | 1.35 | 1.33 | 1.37 | 3.04 |
Jun 27 | 1.34 | 1.31 | 1.36 | 3.61 |
Jun 28 | 1.30 | 1.28 | 1.32 | 2.80 |
Jun 29 | 1.29 | 1.28 | 1.31 | 2.48 |
Jun 30 | 1.30 | 1.29 | 1.32 | 1.90 |
Jul 01 | 1.30 | 1.27 | 1.30 | 2.47 |
Jul 02 | 1.33 | 1.32 | 1.35 | 1.84 |
Jul 03 | 1.36 | 1.35 | 1.38 | 2.21 |
Jul 04 | 1.39 | 1.37 | 1.41 | 3.20 |
Jul 05 | 1.41 | 1.39 | 1.44 | 4.22 |
Jul 06 | 1.41 | 1.38 | 1.42 | 3.00 |
Jul 07 | 1.42 | 1.41 | 1.45 | 2.91 |
Jul 08 | 1.41 | 1.38 | 1.42 | 2.82 |
Jul 09 | 1.40 | 1.37 | 1.41 | 3.04 |
Jul 10 | 1.40 | 1.37 | 1.42 | 3.78 |
Jul 11 | 1.37 | 1.35 | 1.40 | 3.55 |
Jul 12 | 1.36 | 1.34 | 1.37 | 2.04 |
Jul 13 | 1.36 | 1.34 | 1.38 | 3.08 |
Jul 14 | 1.39 | 1.36 | 1.40 | 3.13 |
Jul 15 | 1.40 | 1.38 | 1.42 | 2.68 |
Jul 16 | 1.40 | 1.38 | 1.42 | 3.01 |
Jul 17 | 1.36 | 1.33 | 1.39 | 4.79 |
Jul 18 | 1.37 | 1.36 | 1.39 | 2.18 |
Jul 19 | 1.37 | 1.35 | 1.39 | 2.98 |
Canopy Growth Daily Price Targets
Canopy Growth Stock Forecast 06-20-2025.
Forecast target price for 06-20-2025: $1.34.
Positive dynamics for Canopy Growth shares will prevail with possible volatility of 2.966%.
Pessimistic target level: 1.33
Optimistic target level: 1.37
Canopy Growth Stock Forecast 06-21-2025.
Forecast target price for 06-21-2025: $1.36.
Positive dynamics for Canopy Growth shares will prevail with possible volatility of 2.306%.
Pessimistic target level: 1.35
Optimistic target level: 1.38
Canopy Growth Stock Forecast 06-22-2025.
Forecast target price for 06-22-2025: $1.35.
Negative dynamics for Canopy Growth shares will prevail with possible volatility of 2.449%.
Pessimistic target level: 1.34
Optimistic target level: 1.37
Canopy Growth Stock Forecast 06-23-2025.
Forecast target price for 06-23-2025: $1.35.
Positive dynamics for Canopy Growth shares will prevail with possible volatility of 3.034%.
Pessimistic target level: 1.33
Optimistic target level: 1.37
Canopy Growth Stock Forecast 06-24-2025.
Forecast target price for 06-24-2025: $1.34.
Negative dynamics for Canopy Growth shares will prevail with possible volatility of 3.602%.
Pessimistic target level: 1.31
Optimistic target level: 1.36
Canopy Growth Stock Forecast 06-25-2025.
Forecast target price for 06-25-2025: $1.36.
Positive dynamics for Canopy Growth shares will prevail with possible volatility of 3.291%.
Pessimistic target level: 1.34
Optimistic target level: 1.39
CGC (CGC) Monthly Stock Prediction for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jul. | 1.21 | 1.09 | 1.34 | 18.60 |
Aug. | 1.35 | 1.27 | 1.45 | 12.68 |
Sep. | 1.35 | 1.28 | 1.47 | 12.92 |
Oct. | 1.34 | 1.25 | 1.39 | 9.70 |
Nov. | 1.37 | 1.30 | 1.47 | 11.10 |
Dec. | 1.31 | 1.22 | 1.39 | 12.19 |
Canopy Growth forecast for this year
Canopy Growth Stock Prediction for Jul 2025
An downtrend is forecast for this month with an optimal target price of $1.21. Pessimistic: $1.09. Optimistic: $1.34
Canopy Growth Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $1.34613. Pessimistic: $1.27. Optimistic: $1.45
Canopy Growth Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $1.34613. Pessimistic: $1.28. Optimistic: $1.47
Canopy Growth Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $1.34007. Pessimistic: $1.25. Optimistic: $1.39
Canopy Growth Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $1.37424. Pessimistic: $1.30. Optimistic: $1.47
Canopy Growth Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $1.31034. Pessimistic: $1.22. Optimistic: $1.39
Canopy Growth (CGC) Monthly Stock Prediction for 2026
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 1.22 | 1.14 | 1.34 | 15.44 |
Feb | 1.28 | 1.20 | 1.37 | 12.08 |
Mar | 1.37 | 1.25 | 1.47 | 15.49 |
Apr | 1.18 | 1.08 | 1.23 | 12.24 |
May | 1.08 | 1.05 | 1.12 | 6.51 |
Jun | 1.00 | 0.96 | 1.09 | 12.26 |
Jul | 1.01 | 0.89 | 1.12 | 20.55 |
Aug | 1.06 | 0.95 | 1.14 | 16.65 |
Sep | 1.07 | 0.98 | 1.14 | 14.51 |
Oct | 1.19 | 1.12 | 1.28 | 12.30 |
Nov | 1.23 | 1.16 | 1.29 | 10.29 |
Dec | 1.37 | 1.23 | 1.42 | 13.30 |
Canopy Growth (CGC) Monthly Stock Prediction for 2027
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 1.38 | 1.22 | 1.51 | 18.91 |
Feb | 1.46 | 1.37 | 1.56 | 12.21 |
Mar | 1.35 | 1.26 | 1.44 | 12.68 |
Apr | 1.35 | 1.26 | 1.47 | 14.31 |
May | 1.27 | 1.13 | 1.35 | 15.83 |
Jun | 1.38 | 1.30 | 1.55 | 15.96 |
Jul | 1.48 | 1.31 | 1.59 | 17.91 |
Aug | 1.44 | 1.35 | 1.57 | 13.86 |
Sep | 1.41 | 1.33 | 1.53 | 13.25 |
Oct | 1.43 | 1.31 | 1.50 | 13.13 |
Nov | 1.29 | 1.24 | 1.34 | 7.69 |
Dec | 1.36 | 1.20 | 1.48 | 18.52 |
Canopy Growth information and performance
1 HERSHEY DRIVE, SMITH FALLS, ON, CA
Market capitalization of the Canopy Growth Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CGC shares in the company outstanding by the market price of one share.
EBITDA of Canopy Growth is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Canopy Growth Stock)
Should I Buy Canopy Growth Shares in 2025 year?
Does Canopy Growth pay dividends?
Which economic sector do Canopy Growth's shares belong to?
Which other securities belong to the same sector as Canopy Growth's shares?
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.